240 related articles for article (PubMed ID: 19084810)
1. Characterization of the molecular phenotype of two arrhythmogenic right ventricular cardiomyopathy (ARVC)-related plakophilin-2 (PKP2) mutations.
Joshi-Mukherjee R; Coombs W; Musa H; Oxford E; Taffet S; Delmar M
Heart Rhythm; 2008 Dec; 5(12):1715-23. PubMed ID: 19084810
[TBL] [Abstract][Full Text] [Related]
2. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
[TBL] [Abstract][Full Text] [Related]
3. Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family.
Kannankeril PJ; Bhuiyan ZA; Darbar D; Mannens MM; Wilde AA; Roden DM
Heart Rhythm; 2006 Aug; 3(8):939-44. PubMed ID: 16876743
[TBL] [Abstract][Full Text] [Related]
4. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
[TBL] [Abstract][Full Text] [Related]
5. Disruption of Ca
Kim JC; Pérez-Hernández M; Alvarado FJ; Maurya SR; Montnach J; Yin Y; Zhang M; Lin X; Vasquez C; Heguy A; Liang FX; Woo SH; Morley GE; Rothenberg E; Lundby A; Valdivia HH; Cerrone M; Delmar M
Circulation; 2019 Sep; 140(12):1015-1030. PubMed ID: 31315456
[TBL] [Abstract][Full Text] [Related]
6. High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Hermida A; Fressart V; Hidden-Lucet F; Donal E; Probst V; Deharo JC; Chevalier P; Klug D; Mansencal N; Delacretaz E; Cosnay P; Scanu P; Extramiana F; Keller DI; Rouanet S; Charron P; Gandjbakhch E
Eur J Heart Fail; 2019 Jun; 21(6):792-800. PubMed ID: 30790397
[TBL] [Abstract][Full Text] [Related]
7. Loss of Nuclear Envelope Integrity and Increased Oxidant Production Cause DNA Damage in Adult Hearts Deficient in PKP2: A Molecular Substrate of ARVC.
Pérez-Hernández M; van Opbergen CJM; Bagwan N; Vissing CR; Marrón-Liñares GM; Zhang M; Torres Vega E; Sorrentino A; Drici L; Sulek K; Zhai R; Hansen FB; Christensen AH; Boesgaard S; Gustafsson F; Rossing K; Small EM; Davies MJ; Rothenberg E; Sato PY; Cerrone M; Jensen THL; Qvortrup K; Bundgaard H; Delmar M; Lundby A
Circulation; 2022 Sep; 146(11):851-867. PubMed ID: 35959657
[TBL] [Abstract][Full Text] [Related]
8. Abnormal connexin43 in arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 mutations.
Fidler LM; Wilson GJ; Liu F; Cui X; Scherer SW; Taylor GP; Hamilton RM
J Cell Mol Med; 2009 Oct; 13(10):4219-28. PubMed ID: 18662195
[TBL] [Abstract][Full Text] [Related]
9. Arrhythmogenic right ventricular cardiomyopathy mutations alter shear response without changes in cell-cell adhesion.
Hariharan V; Asimaki A; Michaelson JE; Plovie E; MacRae CA; Saffitz JE; Huang H
Cardiovasc Res; 2014 Nov; 104(2):280-9. PubMed ID: 25253076
[TBL] [Abstract][Full Text] [Related]
10. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy.
van Tintelen JP; Entius MM; Bhuiyan ZA; Jongbloed R; Wiesfeld AC; Wilde AA; van der Smagt J; Boven LG; Mannens MM; van Langen IM; Hofstra RM; Otterspoor LC; Doevendans PA; Rodriguez LM; van Gelder IC; Hauer RN
Circulation; 2006 Apr; 113(13):1650-8. PubMed ID: 16567567
[TBL] [Abstract][Full Text] [Related]
11. Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2.
Cruz FM; Sanz-Rosa D; Roche-Molina M; García-Prieto J; García-Ruiz JM; Pizarro G; Jiménez-Borreguero LJ; Torres M; Bernad A; Ruíz-Cabello J; Fuster V; Ibáñez B; Bernal JA
J Am Coll Cardiol; 2015 Apr; 65(14):1438-50. PubMed ID: 25857910
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic variants in plakophilin-2 gene (PKP2) are associated with better survival in arrhythmogenic right ventricular cardiomyopathy.
Biernacka EK; Borowiec K; Franaszczyk M; Szperl M; Rampazzo A; Woźniak O; Roszczynko M; Śmigielski W; Lutyńska A; Hoffman P
J Appl Genet; 2021 Dec; 62(4):613-620. PubMed ID: 34191271
[TBL] [Abstract][Full Text] [Related]
13. Sequenom MassARRAY approach in the arrhythmogenic right ventricular cardiomyopathy post-mortem setting: clinical and forensic implications.
Alcalde M; Campuzano O; Allegue C; Torres M; Arbelo E; Partemi S; Iglesias A; Brugada J; Oliva A; Carracedo A; Brugada R
Int J Legal Med; 2015 Jan; 129(1):1-10. PubMed ID: 24832006
[TBL] [Abstract][Full Text] [Related]
14. Molecular insights into arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 missense mutations.
Kirchner F; Schuetz A; Boldt LH; Martens K; Dittmar G; Haverkamp W; Thierfelder L; Heinemann U; Gerull B
Circ Cardiovasc Genet; 2012 Aug; 5(4):400-11. PubMed ID: 22781308
[TBL] [Abstract][Full Text] [Related]
15. Characterizing the Molecular Pathology of Arrhythmogenic Cardiomyopathy in Patient Buccal Mucosa Cells.
Asimaki A; Protonotarios A; James CA; Chelko SP; Tichnell C; Murray B; Tsatsopoulou A; Anastasakis A; te Riele A; Kléber AG; Judge DP; Calkins H; Saffitz JE
Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003688. PubMed ID: 26850880
[TBL] [Abstract][Full Text] [Related]
16. [The clinical analysis of plakophilin-2 gene mutation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia].
Liu X; Liu W; Hu D; Zhang L; Zhu T; Li C; Qiu X; Li L; Guo C; Liu X; Wang L; Zheng H; Wang C; Diao Q; Shi D; Zhan P; Deng Y; Liu K; Wang Y; Liu B; Liu H; Qin X; Lan Y
Zhonghua Nei Ke Za Zhi; 2015 Dec; 54(12):1001-6. PubMed ID: 26887364
[TBL] [Abstract][Full Text] [Related]
17. Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy.
Noorman M; Hakim S; Kessler E; Groeneweg JA; Cox MG; Asimaki A; van Rijen HV; van Stuijvenberg L; Chkourko H; van der Heyden MA; Vos MA; de Jonge N; van der Smagt JJ; Dooijes D; Vink A; de Weger RA; Varro A; de Bakker JM; Saffitz JE; Hund TJ; Mohler PJ; Delmar M; Hauer RN; van Veen TA
Heart Rhythm; 2013 Mar; 10(3):412-9. PubMed ID: 23178689
[TBL] [Abstract][Full Text] [Related]
18. Novel mutation of plakophilin-2 associated with arrhythmogenic right ventricular cardiomyopathy.
Nagaoka I; Matsui K; Ueyama T; Kanemoto M; Wu J; Shimizu A; Matsuzaki M; Horie M
Circ J; 2006 Jul; 70(7):933-5. PubMed ID: 16799251
[TBL] [Abstract][Full Text] [Related]
19. Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study.
Cerrone M; Marrón-Liñares GM; van Opbergen CJM; Costa S; Bourfiss M; Pérez-Hernández M; Schlamp F; Sanchis-Gomar F; Malkani K; Drenkova K; Zhang M; Lin X; Heguy A; Velthuis BK; Prakken NHJ; LaGerche A; Calkins H; James CA; Te Riele ASJM; Delmar M
Eur Heart J; 2022 Mar; 43(12):1251-1264. PubMed ID: 34932122
[TBL] [Abstract][Full Text] [Related]
20. Truncating plakophilin-2 mutations in arrhythmogenic cardiomyopathy are associated with protein haploinsufficiency in both myocardium and epidermis.
Rasmussen TB; Nissen PH; Palmfeldt J; Gehmlich K; Dalager S; Jensen UB; Kim WY; Heickendorff L; Mølgaard H; Jensen HK; Baandrup UT; Bross P; Mogensen J
Circ Cardiovasc Genet; 2014 Jun; 7(3):230-40. PubMed ID: 24704780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
